Climate and Health in Maryland:: The Maryland Climate Change Health Adaptation Program.

Maryland's response to climate change has included creation of the Maryland Commission on Climate Change in 2007, and initiatives across many State agencies. The Commission coordinates these initiatives through the State Climate Action Plan. The Maryland Department of Health has partnered with the School of Public Health at the University of Maryland College Park to develop the 2016 Climate and Health Profile report, which estimates the health impacts of climate change in Maryland.

Comparison of Data from a Single-Analyte and a Multianalyte Method for Determination of Urinary Total Deoxynivalenol in Human Samples.

Deoxynivalenol (DON) exposure is estimated by the combined measures of urinary DON and DON-glucuronides. In this study, data from single-mycotoxin (SM) and a multimycotoxin (MM) methods were compared for 256 Swedish adult urine samples. Both methods included β-glucuronidase predigestion, immunoaffinity enrichment, and LC-MS/MS.

Gender differences in a sample of schizophrenic outpatients.

Our objective was to study gender differences in schizophrenia, comparing clinical, social, and illness course characteristics. A sample of 239 schizophrenic (DSM-IV criteria) outpatients were administered the following instruments: service use and demographic questionnaires, the Positive and Negative Symptom Scale (PANSS), the Disability Assessment Scale (DAS), and the Global Assessment of Functioning (GAF) scale. The female to male ratio was 1/2.

[Comparative study of the needs of patients with schizophrenia by gender].

Objectives: To evaluate the gender differences in the needs of the people with schizophrenia who live in the community.

Method: We randomly selected 231 patients with schizophrenia who were receiving treatment in one of the five mental health care centres that participated in the study. Patients were evaluated with a socio-demographic questionnaire, the Positive and Negative Syndromes Scale (PANSS) and Camberwell Assessment of Need (CAN) questionnaire.

[Symptomatology and gender in schizophrenia].

Objective: To study the possible symptomatological gender differences in a sample of schizophrenic outpatients.

Method: A sample of 239 schizophrenic patients (DSM-IV criteria) was administered a demographic questionnaire and the Positive and Negative Syndrome Scale (PANSS). The PANSS symptoms were grouped in accordance with Kay's five factors model.

[Gender differences in schizophrenia. A literature review].

Gender differences in schizophrenia have been the subject of extensive research in the last two decades. The study of these differences can help us improve the understanding of schizophrenia as well as find new treatment options. Recent studies have challenged the classical view that incidence and prevalence rates of schizophrenia are similar in men and in women.